Advance Solid Tumors Harboring The Kras G12c Mutation clinical trials
Explore recruiting advance solid tumors harboring the kras g12c mutation clinical trials.
Also recruiting in Europe
Advance Solid Tumors Harboring The Kras G12c Mutation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.
Advance Solid Tumors Harboring The Kras G12c Mutation trials by city
Advance Solid Tumors Harboring The Kras G12c Mutation in Toronto
Advance Solid Tumors Harboring The Kras G12c Mutation in Vancouver
Advance Solid Tumors Harboring The Kras G12c Mutation in Montreal
Advance Solid Tumors Harboring The Kras G12c Mutation in Calgary
Advance Solid Tumors Harboring The Kras G12c Mutation in Edmonton
Advance Solid Tumors Harboring The Kras G12c Mutation in Ottawa
Advance Solid Tumors Harboring The Kras G12c Mutation in Winnipeg
Advance Solid Tumors Harboring The Kras G12c Mutation in Quebec City
Advance Solid Tumors Harboring The Kras G12c Mutation in Hamilton
Advance Solid Tumors Harboring The Kras G12c Mutation in Kitchener
Advance Solid Tumors Harboring The Kras G12c Mutation in London
Advance Solid Tumors Harboring The Kras G12c Mutation in Halifax
Advance Solid Tumors Harboring The Kras G12c Mutation in New York
Advance Solid Tumors Harboring The Kras G12c Mutation in Los Angeles
Advance Solid Tumors Harboring The Kras G12c Mutation in Chicago
Advance Solid Tumors Harboring The Kras G12c Mutation in Houston
Other conditions
Obesity
Type 2 diabetes
Type 1 diabetes
Prediabetes
Weight loss
Metabolic syndrome
High cholesterol
High triglycerides
High blood pressure
PCOS
Hypothyroidism
Thyroid disease
Gout
Fatty liver disease (NAFLD/NASH)
Heart failure
Coronary artery disease
Atrial fibrillation
Stroke
Stroke recovery
Peripheral artery disease
Pulmonary hypertension
Deep vein thrombosis
Chronic kidney disease
Diabetic kidney disease